Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc

<< Previous

Bullboard Posts

Next >>

Post by SundayMovieson Mar 09, 2023 10:36am

197 Views

Post# 35328036

ONCY trading at 60 millions (excluding 32 millions in cash)

The biggest bargain in town.

Shares are now dirt cheap. The company is worth 60 millions (excluding cash) --- Adlay Nortye licensing deal is now worth more than the company.

A hostile take over is imminent (or)
a minority stake from a potential dark horse...

Management needs to hire strategic advisors now... This will create buzz and help them defend share value...

<< Previous

Bullboard Posts

Next >>

Sony’s Alpha 1 II: A new professional photography standard?